Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Open-label Pilot Study Synbiotic Treatment for Autism Spectrum Disorder [NA]

View source ↗

Summary

An open-label pilot study evaluating a synbiotic treatment for Autism Spectrum Disorder and Anxiety has completed; the document does not provide study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Synbiotic treatment (open-label pilot)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Autism Spectrum Disorder, Anxiety | NA | Status: COMPLETED